On May 14, the House Energy and Commerce Committee advanced its portion of a budget reconciliation bill to meet spending targets included in the budget resolution passed by Congress. As anticipated, Medicaid work requirement provisions are included and preliminary estimates released by the Congressional Budget Office (CBO) show that this provision would reduce federal spending…
Orchid CEO Joe Pomianowski says company’s EHR tools automate much of the clinical note-writing process
ICER found GLP-1 drugs to be cost effective for treating obesity. If that is the case, why don’t more US payers cover the GLP-1 drugs? Clearly, one reason is the cost given the sheer volume of patients i nthe US that are obese; specifically, >40% of US adults are obese. However, a bigger issue may…
By STEVEN ZECOLA The United States healthcare system has failed by any measure. First, costs are out of control. For example, 17% of the country’s GDP is spent on healthcare. This percentage was less than half that amount in 1980. It is expected to continue growing to 20% by 2032. Seventy-five percent of these costs are attributable to…
[Sponsored] A new white paper from LiveWorld highlights how AI tools for healthcare marketers fall short and what’s needed for more effective marketing strategies. The post How Human-Led AI Improves Healthcare Marketing Intelligence appeared first on MedCity News.
By GEORGE BEAUREGARD From 2018 to 2022, I served as a physician executive in a large health system on Long Island. During that period, I became acquainted with the Provost and Executive VP of the New York Institute of Technology. One of the university’s divisions is the New York College of Osteopathic Medicine (NYCOM), one…
At least, it won’t be overturned by the US Supreme Court. Endpoints reports: The Supreme Court says it won’t wade into the pharma industry’s yearslong legal battle over Medicare drug price negotiations. The justices declined to review multiple cases brought by AstraZeneca, Johnson & Johnson, Bristol Myers Squibb, Novo Nordisk, Novartis and Boehringer Ingelheim… The…
[Sponsored] CoraVie Medical CEO Aimee Garza and Dr. Michael Bloch, a hypertension specialist and clinical advisor for the startup, talk about why the healthcare industry needs a better approach to blood pressure monitoring. CoraVie is developing an implantable device that measures patients’ blood pressure, operating in a similar way to continuous glucose monitors. Watch or…
Chris Pricco discusses his priorities as he assumes the role of CEO of APC provider, Marathon Health
Companies say collaboration demonstrates how primary and oncology care can work together to improve quality and lower costs